×
About 995 results

ALLMedicine™ Hepatocellular Adenoma Center

Research & Reviews  491 results

Beta-catenin-activated hepatocellular adenoma in a male.
https://doi.org/10.1007/s12328-021-01372-z 10.1016/j.cgh.2014.05.023 10.1002/hep.22995 10.1053/j.gastro.2016.11.042 10.1002/hep.21068 10.1245/s10434-008-0090-0 10.1136/gut.2010.222109 10.3904/kjim.2009.24.2.147 10.1186/s40880-015-0014-x 10.1016/j.jhep.2010.10.030 10.2217/hep-2017-0023 10.1007/s11604-012-0115-2 10.1148/radiol.11110023 10.1111/hepr.12453 10.1097/PAS.0b013e3182653ece 10.1016/j.cell.2012.05.012
Clinical Journal of Gastroenterology; Ishida R, Yano Y et. al.

Mar 2nd, 2021 - Beta-catenin-activated hepatocellular adenoma is potentially malignant and warrants careful follow-up and surgical resection. Here, we report a 48-year-old man in whom a 55 mm single liver tumor was incidentally detected in the S1 segment. Contras...

Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-muta...
https://doi.org/10.1097/PAS.0000000000001675
The American Journal of Surgical Pathology; Sempoux C, Gouw ASH et. al.

Feb 9th, 2021 - Some hepatocellular adenoma (HCA) subtypes are characterized by different CTNNB1 mutations, leading to different beta-catenin activation levels, hence variable immunostaining patterns of glutamine synthetase (GS) expression, and different risks of...

Surgical outcomes of laparoscopic and open resection of benign liver tumours in the Net...
https://doi.org/10.1016/j.hpb.2020.12.003
HPB : the Official Journal of the International Hepato Pa... Elfrink AKE, Haring MPD et. al.

Jan 22nd, 2021 - Data on surgical outcomes of laparoscopic liver resection (LLR) versus open liver resection (OLR) of benign liver tumour (BLT) are scarce. This study aimed to provide a nationwide overview of postoperative outcomes after LLR and OLR of BLT. This w...

Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomark...
https://doi.org/10.1007/s00330-020-07434-z
European Radiology; Reizine E, Ronot M et. al.

Nov 4th, 2020 - To assess the value of hepatospecific MR contrast agent uptake on hepatobiliary phase (HBP) images to detect marked activation of the β-catenin pathway in hepatocellular adenomas (HCAs). This multicentric retrospective IRB-approved study included ...

Diagnostic value of clusterin immunostaining in hepatocellular carcinoma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559739
Diagnostic Pathology; Li Y, Liu F et. al.

Oct 15th, 2020 - Histologic distinction between well differentiated hepatocellular carcinoma (HCC) and benign hepatocellular mass lesions is a known challenge. Existing biomarkers are of limited diagnostic value. Our previous studies observed an enhanced canalicul...

see more →

Guidelines  1 results

ACG clinical guideline: the diagnosis and management of focal liver lesions.
https://doi.org/10.1038/ajg.2014.213
The American Journal of Gastroenterology; Marrero JA, Ahn J et. al.

Aug 19th, 2014 - Focal liver lesions (FLL) have been a common reason for consultation faced by gastroenterologists and hepatologists. The increasing and widespread use of imaging studies has led to an increase in detection of incidental FLL. It is important to con...

see more →

Clinicaltrials.gov  499 results

Beta-catenin-activated hepatocellular adenoma in a male.
https://doi.org/10.1007/s12328-021-01372-z 10.1016/j.cgh.2014.05.023 10.1002/hep.22995 10.1053/j.gastro.2016.11.042 10.1002/hep.21068 10.1245/s10434-008-0090-0 10.1136/gut.2010.222109 10.3904/kjim.2009.24.2.147 10.1186/s40880-015-0014-x 10.1016/j.jhep.2010.10.030 10.2217/hep-2017-0023 10.1007/s11604-012-0115-2 10.1148/radiol.11110023 10.1111/hepr.12453 10.1097/PAS.0b013e3182653ece 10.1016/j.cell.2012.05.012
Clinical Journal of Gastroenterology; Ishida R, Yano Y et. al.

Mar 2nd, 2021 - Beta-catenin-activated hepatocellular adenoma is potentially malignant and warrants careful follow-up and surgical resection. Here, we report a 48-year-old man in whom a 55 mm single liver tumor was incidentally detected in the S1 segment. Contras...

Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-muta...
https://doi.org/10.1097/PAS.0000000000001675
The American Journal of Surgical Pathology; Sempoux C, Gouw ASH et. al.

Feb 9th, 2021 - Some hepatocellular adenoma (HCA) subtypes are characterized by different CTNNB1 mutations, leading to different beta-catenin activation levels, hence variable immunostaining patterns of glutamine synthetase (GS) expression, and different risks of...

Surgical outcomes of laparoscopic and open resection of benign liver tumours in the Net...
https://doi.org/10.1016/j.hpb.2020.12.003
HPB : the Official Journal of the International Hepato Pa... Elfrink AKE, Haring MPD et. al.

Jan 22nd, 2021 - Data on surgical outcomes of laparoscopic liver resection (LLR) versus open liver resection (OLR) of benign liver tumour (BLT) are scarce. This study aimed to provide a nationwide overview of postoperative outcomes after LLR and OLR of BLT. This w...

Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomark...
https://doi.org/10.1007/s00330-020-07434-z
European Radiology; Reizine E, Ronot M et. al.

Nov 4th, 2020 - To assess the value of hepatospecific MR contrast agent uptake on hepatobiliary phase (HBP) images to detect marked activation of the β-catenin pathway in hepatocellular adenomas (HCAs). This multicentric retrospective IRB-approved study included ...

Diagnostic value of clusterin immunostaining in hepatocellular carcinoma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559739
Diagnostic Pathology; Li Y, Liu F et. al.

Oct 15th, 2020 - Histologic distinction between well differentiated hepatocellular carcinoma (HCC) and benign hepatocellular mass lesions is a known challenge. Existing biomarkers are of limited diagnostic value. Our previous studies observed an enhanced canalicul...

see more →

News  4 results

The Differential Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia
https://www.medscape.com/viewarticle/761967

Apr 17th, 2012 - Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid-Enhanced MR Imaging in Differential Diagnosis Grazioli L, Bondioni MP, Haradome H, et al Radiology. 2012;262:520-529 Summary The goal of this project was to retrospectiv...

Update: Radiologic-Pathologic Correlation of Hepatocellular Adenoma
https://www.medscape.com/viewarticle/922023_2

Epidemiology and Etiologic Associations Hepatocellular adenoma has an incidence of 1–1.3 million cases per year in North America and Europe.[12] Several studies have consistently linked the occurrence of HAs to oral contraceptive pill (OCP) use.[1...

Update: Radiologic-Pathologic Correlation of Hepatocellular Adenoma
https://www.medscape.com/viewarticle/922023

Abstract and Introduction Introduction Hepatocellular adenoma (HA) is a relatively uncommon benign liver neoplasm that is typically seen in obese women of childbearing age who are on long-term oral contraceptives.[1] It is also reported to occur i...

Update: Radiologic-Pathologic Correlation of Hepatocellular Adenoma
https://www.medscape.com/viewarticle/922023_3

Clinical Presentation The majority of HAs are clinically occult and are incidentally detected on imaging. The risk factors for hemorrhage are size >5 cm, a subcapsular location and longstanding OCP use.[10,18,19] HCA associated with hemorrhage may...

see more →